Earnings Outlook For Xeris Biopharma Holdings
Portfolio Pulse from Benzinga Insights
Xeris Biopharma Holdings (NASDAQ:XERS) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. The company's shares are currently trading at $2.64 and have seen a 49.41% increase over the last 52-week period.
August 07, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xeris Biopharma Holdings is expected to release its earnings report on August 8, 2023. The company has a history of beating EPS estimates, which could potentially lead to an increase in its share price.
Xeris Biopharma Holdings has a history of beating EPS estimates, which has often led to an increase in its share price. Given this pattern and the positive analyst estimate for the upcoming earnings report, it is likely that the company's share price will increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100